Stress ulcer prophylaxis versus placebo—a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD)

Stress ulcer prophylaxis versus placebo—a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD)

Abstract Background Critically ill infants with congenital heart disease (CHD) are often prescribed stress ulcer prophylaxis (SUP) to prevent upper gastrointestinal bleeding, despite the low incidence of stress ulcers and limited data on the safety and efficacy of SUP in infants. Recently, SUP has b...

Full description

Bibliographic Details
Main Authors: Kimberly I. Mills, Ben D. Albert, Lori J. Bechard, Christopher P. Duggan, Aditya Kaza, Seth Rakoff-Nahoum, Hera Vlamakis, Lynn A. Sleeper, Jane W. Newburger, Gregory P. Priebe, Nilesh M. Mehta
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Pediatric critical care
Pediatric cardiac critical care
Pediatric intensive care
H2 blocker
Congenital heart disease
Gastrointestinal hemorrhage
Online Access:http://link.springer.com/article/10.1186/s13063-020-04513-w

Internet

http://link.springer.com/article/10.1186/s13063-020-04513-w

Similar Items